IP Library Granted Patent US 9,102,939
Granted Patent B2
US 9,102,939 · App. 13/647,177 · Granted Aug 11, 2015

Genetic inhibition by double-stranded RNA

Inventors: Andrew Fire (Baltimore, MD); Stephen Kostas (Towson, MD); Mary Montgomery (St. Paul, MN); Lisa Timmons (Lawrence, KS); SiQun Xu (Ballwin, MO); Hiroaki Tabara (Mishima, JP); Samuel E. Driver (Providence, RI); Craig C. Mello (Shrewsbury, MA)
Assignees: The Carnegie Institution of Washington; The University of Massachusetts
C12N15/113A61K31/713A61K31/7105C12N15/8218C12N15/85A01K2217/05A01K2227/703C12N2310/11C12N2310/14C12N2310/321C12N2310/50C12N2310/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,939
App. No.
13/647,177
Granted
Aug 11, 2015
Kind
B2
Abstract

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Claims (19)

1. A method to inhibit expression of a target gene in an animal cell comprising introduction of a ribonucleic acid (RNA) into the cell in an amount sufficient to inhibit expression of the target gene, wherein the RNA comprises a double-stranded structure with an identical nucleotide sequence as compared to a portion of the target gene.

2. The method of claim 1 in which the target gene is a cellular gene.

3. The method of claim 1 in which the target gene is an endogenous gene.

4. The method of claim 1 in which the target gene is a transgene.

5. The method of claim 1 in which the target gene is a viral gene.

6. The method of claim 1 in which the cell is from an invertebrate animal.

7. The method of claim 6 in which the cell is from a nematode.

8. The method of claim 1 in which the identical nucleotide sequence is at least 50 bases in length.

9. The method of claim 1 in which the target gene expression is inhibited by at least 10%.

10. The method of claim 1 in which the cell is present in an organism and inhibition of target gene expression demonstrates a loss-of function phenotype.

11. The method of claim 1 in which the RNA comprises one strand which is self complementary.

12. The method of claim 1 in which the RNA comprises two separate complementary strands.

13. The method of claim 12 further comprising synthesis of the two complementary strands and initiation of RNA duplex formation outside the cell.

14. The method of claim 12 further comprising synthesis of the two complementary strands and initiation of RNA duplex formation inside the cell.

15. The method of claim 1 in which the cell is present in an organism, and the RNA is introduced within a body cavity of the organism and outside the cell.

16. The method of claim 1 in which the cell is present in an organism and the RNA is introduced by extracellular injection into the organism.

17. The method of claim 1 in which the cell is present in a first organism, and the RNA is introduced to the first organism by feeding a second, RNA-containing organism to the first organism.

18. The method of claim 17 in which the second organism is engineered to produce an RNA duplex.

19. The method of claim 1 in which an expression construct in the cell produces the RNA.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 28, 2015
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036700/0873 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: FIRE, ANDREW; XU, SIQUN; MONTGOMERY, MARY K.; KOSTAS, STEPHEN A.; TIMMONS, LISA
To: THE CARNEGIE INSTITUTION OF WASHINGTON
Reel/Frame 032194/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: TABARA, HIROAKI; DRIVER, SAMUEL E.; MELLO, CRAIG C.
To: THE UNIVERSITY OF MASSACHUSETTS
Reel/Frame 032194/0049 →
Continuity (5)
Continuation 11905368 · Sep 28, 2007
Continuation 10282996 · Oct 30, 2002
Continuation 09215257 · Dec 18, 1998
Provisional Application 60068562 · Dec 23, 1997
Related Publication 20130230492A1 · Sep 5, 2013